Skip to main content
DVx Inc. logo

DVx Inc. — Investor Relations & Filings

Ticker · 3079 ISIN · JP3548710007 T Manufacturing
Open in API
Filings indexed 62 across all filing types
Latest filing 2024-07-01 Governance Information
Country JP Japan
Listing T 3079

About DVx Inc.

https://www.dvx.jp/

DVx Inc. is a company that provides sales and solutions for advanced medical devices, primarily focusing on the cardiovascular disease field. Its operations encompass the entire lifecycle of medical equipment, including research and development, design, manufacturing, import/export, purchasing, and sales. The company's product portfolio is centered on the treatment of arrhythmia and includes devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and ablation catheters. In addition to product distribution, DVx Inc. offers comprehensive support services, which include the repair, maintenance, inspection, and rental of medical devices.

Recent filings

Filing Released Lang Actions
内部統制報告書－第38期(2023/04/01－2024/03/31)
Governance Information Classification · 1% confidence The document header explicitly states the filing type as "内部統制報告書" (Internal Control Report) and cites the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項). The content discusses the framework, scope, procedures, and conclusion regarding the assessment of internal controls over financial reporting (財務報告に係る内部統制). This directly corresponds to the requirements for an internal control report, which is typically filed alongside the Annual Report (10-K) but is a distinct regulatory document in Japan. Given the provided classification options, the closest fit for a comprehensive report detailing internal controls and audit-related principles, though not a standalone audit report (AR), is often categorized under broader reporting or specific regulatory filings. However, since the document is a full, detailed report on internal controls, and not just an announcement of a report, it is not RPA or RNS. In the context of US filings, this is often part of the 10-K, but since this is a Japanese filing, and 'AR' is defined as 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests', this document, being the formal internal control assessment, fits best under 'AR' as it deals with internal control standards and assessment principles, which are closely related to auditing standards. If a specific 'Internal Control Report' code existed, it would be used, but 'AR' is the most appropriate category among the choices for a detailed internal control assessment document.
2024-07-01 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is extremely short (576 characters) and contains a table structure typical of a cover page for a regulatory filing in Japan. Key Japanese terms include '【提出書類】確認書' (Filing Document: Confirmation Document), '【根拠条文】金融商品取引法' (Legal Basis: Financial Instruments and Exchange Act), and references to a '四半期報告書' (Quarterly Report) for the period ending December 31, 2023. The content explicitly states that the President confirmed the appropriateness of the Quarterly Report's contents based on the Financial Instruments and Exchange Act. This document is not the Quarterly Report itself, but a formal confirmation/attestation regarding its accuracy, which falls under the category of a regulatory filing or confirmation document. Given the specific context of confirming the accuracy of a Quarterly Report (which is an 'IR' document), this confirmation document itself is best classified as a general Regulatory Filing (RNS) or potentially a specific confirmation document if one existed, but RNS is the best fit among the provided options for a short, formal regulatory attestation that isn't the main report.
2024-02-14 Japanese
四半期報告書－第38期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements (balance sheet, income statement) for the third quarter of the 38th fiscal year (April 1, 2023, to December 31, 2023). It is not an announcement or a certification, but the full report itself, which fits the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-14 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is extremely short (575 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning a '確認書' (Confirmation Document) submitted to the '関東財務局長' (Kanto Local Finance Bureau Director) under the Financial Instruments and Exchange Act. The core content confirms the appropriateness of the '第38期第２四半期' (38th Fiscal Year, Second Quarter) '四半期報告書' (Quarterly Report) filed by the CEO. Since this document is a confirmation *about* the Quarterly Report, and not the comprehensive report itself, it fits best under a general regulatory announcement category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific confirmation document that isn't a standard financial report (like IR or 10-K) or a specific announcement like a dividend or management change. However, since the document explicitly deals with the Quarterly Report confirmation, and there is no specific code for 'Confirmation of Quarterly Report', I must check if any other code fits better. 'IR' (Interim/Quarterly Report) is for the comprehensive report. This is a confirmation *of* the report. Given the nature of Japanese filings, this confirmation document often accompanies the main filing. Since it is a regulatory document confirming the accuracy of a quarterly filing, RNS (Regulatory Filings) is the best fit as a general regulatory submission that doesn't match the specific financial report codes.
2023-11-14 Japanese
四半期報告書－第38期第2四半期(2022/07/01－2023/09/30)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements (balance sheets, income statements, etc.) for the second quarter of the 38th fiscal period (April 1, 2023, to September 30, 2023). It includes management analysis, shareholding information, and audit review information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 38
2023-11-14 Japanese
四半期報告書－第38期第1四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan. It covers the first quarter of the 38th fiscal period (April 1, 2023, to June 30, 2023). It contains detailed financial statements, including the balance sheet and income statement, and management's analysis of financial results. This fits the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-08-14 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.